Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  HIV Infection

  Free Subscription


12.02.2018

1 Am J Epidemiol
1 BMC Pediatr
7 Clin Infect Dis
8 J Acquir Immune Defic Syndr
5 J Infect Dis
1 J Med Virol
7 Lancet Infect Dis
1 N Engl J Med
1 Pediatr Infect Dis J
24 PLoS One
1 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. EDWARDS JK, Cole SR, Moore RD, Mathews WC, et al
    Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula.
    Am J Epidemiol. 2018 Feb 6. pii: 4840735. doi: 10.1093.
    PubMed     Text format     Abstract available


    BMC Pediatr

  2. AMOROSO CL, Nisingizwe MP, Rouleau D, Thomson DR, et al
    Next wave of interventions to reduce under-five mortality in Rwanda: a cross-sectional analysis of demographic and health survey data.
    BMC Pediatr. 2018;18:27.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  3. DINH TH, Mushavi A, Shiraishi RW, Tippett Barr B, et al
    Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition
    Clin Infect Dis. 2018;66:576-585.
    PubMed     Text format     Abstract available

  4. GLIDDEN DV, Mulligan K, McMahan V, Anderson PL, et al
    Metabolic Effects of Pre-Exposure Prophylaxis with Co-Formulated Tenofovir Disoproxal Fumarate and Emtricitabine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836821. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. BROOKS KM, George JM, Pau AK, Rupert A, et al
    Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir with Once-Weekly Isoniazid and Rifapentine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836314. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. QI Q, Hua S, Clish CB, Scott JM, et al
    Plasma tryptophan-kynurenine metabolites are altered in HIV infection and associated with progression of carotid artery atherosclerosis.
    Clin Infect Dis. 2018 Feb 3. pii: 4837274. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. GRANT RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, et al
    Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
    Clin Infect Dis. 2018 Feb 6. pii: 4840078. doi: 10.1093/cid/cix1086.
    PubMed     Text format     Abstract available

  8. CHAMBERS LC, Khosropour CM, Katz DA, Dombrowski JC, et al
    Racial/ethnic disparities in the lifetime risk of Chlamydia trachomatis diagnosis and adverse reproductive health outcomes among women in King County, Washington.
    Clin Infect Dis. 2018 Feb 6. pii: 4840254. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. BAROCAS JA, Tasillo A, Eftekhari Yazdi G, Wang J, et al
    Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
    Clin Infect Dis. 2018 Feb 6. pii: 4840186. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  10. NGONGONDO M, Miyahara S, Hughes MD, Sun X, et al
    Hepatotoxicity during Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living with HIV with Severe Immunosuppression: a Secondary Analysis of a Multi-country Open-label Randomized Controlled Clinical Trial.
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001641.
    PubMed     Text format     Abstract available

  11. KALICHMAN SC, Cherry C, Kalichman MO, Eaton LA, et al
    Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001637.
    PubMed     Text format     Abstract available

  12. FLORIDIA M, Pinnetti C, Ravizza M, Masuelli G, et al
    Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women with Hiv: Laboratory and Clinical Outcomes in an Observational National Study.
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001640.
    PubMed     Text format     Abstract available

  13. GOYETTE MS, Mutiti PM, Bukusi D, MMEd, et al
    Hiv Assisted Partner Services Among Those with and Without A History of Intimate Partner Violence in Kenya.
    J Acquir Immune Defic Syndr. 2018 Feb 5. doi: 10.1097/QAI.0000000000001638.
    PubMed     Text format     Abstract available

  14. FULCHER JA, Shoptaw S, Makgoeng SB, Elliott J, et al
    Recent Methamphetamine Use is Associated with Increased Rectal Mucosal Inflammatory Cytokines Regardless of HIV-1 Serostatus.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001643.
    PubMed     Text format     Abstract available

  15. ELION RA, Althoff KN, Zhang J, Moore RD, et al
    Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001642.
    PubMed     Text format     Abstract available

  16. DEFILIPPI C, Christenson R, Joyce J, Park EA, et al
    Statin Effects on Myocardial Fibrosis Markers in People Living with HIV.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001644.
    PubMed     Text format     Abstract available

  17. TUMARKIN E, Heendeniya A, Murphy P, Placido T, et al
    HIV Post-Exposure Prophylaxis-in-Pocket ("PIP") for individuals with low frequency, high risk, HIV exposures.
    J Acquir Immune Defic Syndr. 2018 Feb 6. doi: 10.1097/QAI.0000000000001639.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. COMBES JD, Heard I, Poizot-Martin I, Canestri A, et al
    Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men.
    J Infect Dis. 2018 Jan 31. pii: 4830905. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. CLIFFORD DB
    Could We Harness Human Immunodeficiency Virus Antibodies to Monitor the Brain?
    J Infect Dis. 2018 Feb 1. pii: 4832662. doi: 10.1093.
    PubMed     Text format    

  20. BURBELO PD, Price RW, Hagberg L, Hatano H, et al
    Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    J Infect Dis. 2018 Feb 1. pii: 4834093. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. SHANG L, Smith AJ, Duan L, Perkey KE, et al
    Vaccine-associated maintenance of epithelial integrity correlated with protection against virus entry.
    J Infect Dis. 2018 Feb 1. pii: 4833184. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. UTAY NS, Kitch DW, Yeh E, Fichtenbaum CJ, et al
    Telmisartan Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued ART Alone.
    J Infect Dis. 2018 Feb 1. pii: 4833221. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  23. RAO D, Venkataswamy MM, Vasanthapuram R, Satishchandra P, et al
    Alterations in natural killer and dendritic cell subsets in individuals with HIV-associated neurotuberculosis.
    J Med Virol. 2018 Feb 3. doi: 10.1002/jmv.25042.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  24. VAN LAARHOVEN A, Dian S, Aguirre-Gamboa R, Avila-Pacheco J, et al
    Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.
    Lancet Infect Dis. 2018 Jan 23. pii: S1473-3099(18)30053.
    PubMed     Text format     Abstract available

  25. COLEMAN BW, Sereti I, Bishop R, Smith BR, et al
    Upbeat nystagmus in an HIV-positive patient with a tuberculoma in the medulla.
    Lancet Infect Dis. 2018;18:225.
    PubMed     Text format    

  26. ASSEFA Y
    Expansion of the WHO public health approach to HIV.
    Lancet Infect Dis. 2018;18:143-144.
    PubMed     Text format    

  27. KOUDOU BG, de Souza DK, Biritwum NK, Bougma R, et al
    Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?
    Lancet Infect Dis. 2018 Feb 2. pii: S1473-3099(18)30069.
    PubMed     Text format     Abstract available

  28. MCCLELLAND RS, Lingappa JR, Srinivasan S, Kinuthia J, et al
    Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.
    Lancet Infect Dis. 2018 Jan 25. pii: S1473-3099(18)30058.
    PubMed     Text format     Abstract available

  29. PASSMORE JS, Jaspan HB
    Vaginal microbes, inflammation, and HIV risk in African women.
    Lancet Infect Dis. 2018 Jan 25. pii: S1473-3099(18)30061.
    PubMed     Text format    

  30. DESAI M, Hill J, Fernandes S, Walker P, et al
    Prevention of malaria in pregnancy.
    Lancet Infect Dis. 2018 Jan 30. pii: S1473-3099(18)30064.
    PubMed     Text format     Abstract available


    N Engl J Med

  31. FAUCI AS, Eisinger RW
    PEPFAR - 15 Years and Counting the Lives Saved.
    N Engl J Med. 2018;378:314-316.
    PubMed     Text format    


    Pediatr Infect Dis J

  32. JESSON J, Dahourou DL, Folquet MA, Malateste K, et al
    Malnutrition, Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-Infected Children Treated Before the Age of Two Years in West Africa.
    Pediatr Infect Dis J. 2018 Feb 3. doi: 10.1097/INF.0000000000001932.
    PubMed     Text format     Abstract available


    PLoS One

  33. LASSER KE, Lunze K, Cheng DM, Blokhina E, et al
    Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study.
    PLoS One. 2018;13:e0189207.
    PubMed     Text format     Abstract available

  34. STOCKDALE L, Nash S, Nalwoga A, Painter H, et al
    Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
    PLoS One. 2018;13:e0192086.
    PubMed     Text format     Abstract available

  35. SHIELDS MD, ALQahtani F, Rivey MP, McElnay JC, et al
    Mobile direct observation of therapy (MDOT) - A rapid systematic review and pilot study in children with asthma.
    PLoS One. 2018;13:e0190031.
    PubMed     Text format     Abstract available

  36. SABALZA M, Yasmin R, Barber CA, Castro T, et al
    Detection of Zika virus using reverse-transcription LAMP coupled with reverse dot blot analysis in saliva.
    PLoS One. 2018;13:e0192398.
    PubMed     Text format     Abstract available

  37. MAYAPHI SH, Martin DJ, Olorunju SAS, Williams BG, et al
    High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures.
    PLoS One. 2018;13:e0192357.
    PubMed     Text format     Abstract available

  38. SEIPONE ID, Singh R, Patel VB, Singh A, et al
    Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.
    PLoS One. 2018;13:e0192060.
    PubMed     Text format     Abstract available

  39. SHELUS V, Taylor J, Greene E, Stanton J, et al
    It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study.
    PLoS One. 2018;13:e0191638.
    PubMed     Text format     Abstract available

  40. SACOOR C, Payne B, Augusto O, Vilanculo F, et al
    Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique.
    PLoS One. 2018;13:e0184249.
    PubMed     Text format     Abstract available

  41. ZAHR NM
    Peripheral TNFalpha elevations in abstinent alcoholics are associated with hepatitis C infection.
    PLoS One. 2018;13:e0191586.
    PubMed     Text format     Abstract available

  42. BELYHUN Y, Liebert UG, Maier M
    Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
    PLoS One. 2018;13:e0191970.
    PubMed     Text format     Abstract available

  43. VEESA KS, John KR, Moonan PK, Kaliappan SP, et al
    Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
    PLoS One. 2018;13:e0191591.
    PubMed     Text format     Abstract available

  44. BERMUDEZ-AZA EH, Shetty S, Ousley J, Kyaw NTT, et al
    Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.
    PLoS One. 2018;13:e0191695.
    PubMed     Text format     Abstract available

  45. ARMSTRONG-HOUGH M, Kishore SP, Byakika S, Mutungi G, et al
    Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment.
    PLoS One. 2018;13:e0192332.
    PubMed     Text format     Abstract available

  46. MUSUMARI PM, Tangmunkongvorakul A, Srithanaviboonchai K, Feldman MD, et al
    Correction: Socio-behavioral risk factors among older adults living with HIV in Thailand.
    PLoS One. 2018;13:e0192818.
    PubMed     Text format     Abstract available

  47. PERCIANI CT, Jaoko W, Farah B, Ostrowski MA, et al
    alphaEbeta7, alpha4beta7 and alpha4beta1 integrin contributions to T cell distribution in blood, cervix and rectal tissues: Potential implications for HIV transmission.
    PLoS One. 2018;13:e0192482.
    PubMed     Text format     Abstract available

  48. NACHER M, Adriouch L, Van Melle A, Parriault MC, et al
    Country of infection among HIV-infected patients born abroad living in French Guiana.
    PLoS One. 2018;13:e0192564.
    PubMed     Text format     Abstract available

  49. MAMULWAR M, Godbole S, Bembalkar S, Kamble P, et al
    Differing HIV vulnerability among female sex workers in a high HIV burden Indian state.
    PLoS One. 2018;13:e0192130.
    PubMed     Text format     Abstract available

  50. ATUJUNA M, Newman PA, Wallace M, Eluhu M, et al
    Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
    PLoS One. 2018;13:e0191251.
    PubMed     Text format     Abstract available

  51. DING J, Zhao J, Zhou J, Li X, et al
    Association of gene polymorphism of SDF1(CXCR12) with susceptibility to HIV-1 infection and AIDS disease progression: A meta-analysis.
    PLoS One. 2018;13:e0191930.
    PubMed     Text format     Abstract available

  52. BAMOROVAT M, Sharifi I, Aflatoonian MR, Sharifi H, et al
    Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.
    PLoS One. 2018;13:e0192236.
    PubMed     Text format     Abstract available

  53. MATOGA MM, Rosenberg NE, Stanley CC, LaCourse S, et al
    Inpatient mortality rates during an era of increased access to HIV testing and ART: A prospective observational study in Lilongwe, Malawi.
    PLoS One. 2018;13:e0191944.
    PubMed     Text format     Abstract available

  54. GILL MM, Mofenson LM, Phalatse M, Tukei V, et al
    Piloting very early infant diagnosis of HIV in Lesotho: Acceptability and feasibility among mothers, health workers and laboratory personnel.
    PLoS One. 2018;13:e0190874.
    PubMed     Text format     Abstract available

  55. WU M, Alvarado JJ, Augelli-Szafran CE, Ptak RG, et al
    A single beta-octyl glucoside molecule induces HIV-1 Nef dimer formation in the absence of partner protein binding.
    PLoS One. 2018;13:e0192512.
    PubMed     Text format     Abstract available

  56. QIAO S, Zhang Y, Li X, Menon JA, et al
    Facilitators and barriers for HIV-testing in Zambia: A systematic review of multi-level factors.
    PLoS One. 2018;13:e0192327.
    PubMed     Text format     Abstract available


    Vaccine

  57. THIAM-DIOUF A, Metch B, Sharpe C, Mulugeta R, et al
    Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.
    Vaccine. 2018;36:1235-1242.
    PubMed     Text format     Abstract available


    Virology

  58. KHAN AS, Bodem J, Buseyne F, Gessain A, et al
    Spumaretroviruses: Updated taxonomy and nomenclature.
    Virology. 2018;516:158-164.
    PubMed     Text format     Abstract available

  59. SERTZNIG H, Hillebrand F, Erkelenz S, Schaal H, et al
    Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet.
    Virology. 2018;516:176-188.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: